Susquehanna International Group, LLP Bausch Health Companies Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $1.16 Million - $1.84 Million	222,700 Added 76.61%	513,400 $4.18 Million
Q2 2024 Aug 15, 2024	SELL	$6.1 - $10.41 $27.7 Million - $47.2 Million	-4,536,100 Reduced 93.98%	290,700 $2.03 Million
Q1 2024 May 07, 2024	BUY	$7.77 - $10.61 $33.9 Million - $46.3 Million	4,363,700 Added 942.28%	4,826,800 $51.2 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $10.2 Million - $12.9 Million	-1,569,100 Reduced 77.21%	463,100 $3.71 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $12 Million - $15.1 Million	1,559,600 Added 330.0%	2,032,200 $16.7 Million
Q2 2023 Aug 11, 2023	SELL	$5.72 - $8.8 $4.48 Million - $6.89 Million	-782,600 Reduced 62.35%	472,600 $3.78 Million
Q1 2023 May 16, 2023	SELL	$6.28 - $9.85 $639,932 - $1 Million	-101,900 Reduced 7.51%	1,255,200 $10.2 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $15.6 Million - $20.4 Million	-2,569,500 Reduced 65.44%	1,357,100 $8.52 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $11.2 Million - $22.5 Million	2,441,200 Added 164.35%	3,926,600 $27.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.81 Million - $6.06 Million	-256,600 Reduced 14.73%	1,485,400 $12.4 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $25.6 Million - $32.9 Million	-1,184,200 Reduced 40.47%	1,742,000 $39.8 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $8.25 Million - $10.4 Million	358,900 Added 13.98%	2,926,200 $80.8 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $16.1 Million - $19.3 Million	641,900 Added 33.34%	2,567,300 $71.5 Million
Q2 2021 Aug 11, 2021	SELL	$27.43 - $32.7 $12.3 Million - $14.7 Million	-449,400 Reduced 18.92%	1,925,400 $56.5 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $11.1 Million - $17.8 Million	-519,000 Reduced 17.93%	2,374,800 $75.4 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $8.15 Million - $11.2 Million	532,200 Added 22.54%	2,893,800 $60.2 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $8.95 Million - $12.1 Million	601,700 Added 34.19%	2,361,600 $36.7 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $1.41 Million - $2.17 Million	105,900 Added 6.4%	1,759,900 $32.2 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $90.9 Million - $212 Million	-7,000,900 Reduced 80.89%	1,654,000 $25.6 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $122 Million - $206 Million	6,467,700 Added 295.71%	8,654,900 $259 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $28.4 Million - $34.9 Million	-1,360,300 Reduced 38.35%	2,187,200 $47.8 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $11.7 Million - $15.1 Million	-571,400 Reduced 13.87%	3,547,500 $89.5 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $29.9 Million - $38.8 Million	-1,477,700 Reduced 26.4%	4,118,900 $102 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $5.72 Million - $9.18 Million	-324,300 Reduced 5.48%	5,596,600 $103 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $122 Million - $152 Million	5,920,900 New	5,920,900 $152 Million

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

Icahn Carl C Sunny Isles Beach, FL

34.7M
Shares

$257 Million
2.88% of portfolio
Goldentree Asset Management LP New York, NY

29.4M
Shares

$217 Million
21.8% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

26.4M
Shares

$195 Million
14.7% of portfolio
National Bank Of Canada

15.6M
Shares

$116 Million
0.18% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13M
Shares

$96.1 Million
0.26% of portfolio

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account